Non-muscle Invasive Bladder Cancer
📧 Sign up to get email alerts when something new happens for Non-muscle Invasive Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-10-04Clinical Trial Update: Preoperative Intravesical Electromotive Mitomycin-c for Primary Non-muscle Invasive Bladder Cancer [Phase 3]
Phase 3 trial of preoperative intravesical electromotive mitomycin-C for primary non-muscle invasive bladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2011-03-04Clinical Trial Update: Combined Use of BCG and Interferon Alpha in Bladder Cancer [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluating the combination of Bacillus Calmette-Guérin (BCG) and Interferon Alpha for superficial bladd…
-
CLINICAL_TRIALS trial_result · 2010-02-08Clinical Trial Update: Study of Immediate Post-Operative Intravesical Instillation of Chemophase® in Patients With Superficial Bladder Cancer [Phase 1]
Phase 1 study evaluating immediate post-operative intravesical instillation of Chemophase in patients with non-muscle-invasive bladder cance…
-
CLINICAL_TRIALS trial_result · 2008-06-12Clinical Trial Update: Bacillus of Calmette and Guerin (BCG) Versus Gemcitabine For Intravesical Therapy In High Risk Superficial Bladder Cancer [Phase 1, Phase 2]
This document reports the completion of a Phase 1/2 clinical trial comparing intravesical Bacillus Calmette-Guérin (BCG) to Gemcitabine in p…
-
CLINICAL_TRIALS trial_result · 2008-01-07Clinical Trial Update: Safety and Proof of Concept Study of Intravesical DTA-H19 in Patients With Superficial Bladder Cancer [Phase 1, Phase 2]
This clinical trial update reports safety and proof-of-concept results from a Phase 1/2 study of intravesical DTA-H19 in patients with super…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-05-17Clinical Trial Update: A Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder Cancer [Phase 2]
A completed Phase 2 randomized trial comparing intravesical gemcitabine monotherapy against mitomycin C for intermediate-risk non-muscle inv…